文献速递神经与头颈病理

滤泡细胞起源甲状腺肿瘤的分子病理:遗传改变及其临床病理相关性综述

Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
PubMed 文献 · Histopathology · 2018-01-01

甲状腺癌是最常见的内分泌恶性肿瘤。本文综述了滤泡细胞起源甲状腺肿瘤的主要遗传改变,包括BRAF p.V600E、RAS点突变和融合癌基因(以RET-PTC为原型),分别与经典型乳头状癌、滤泡型肿瘤(滤泡腺瘤、滤泡癌及乳头状癌滤泡型/伴乳头状核特征的非浸润性滤泡性甲状腺肿瘤)以及年轻患者和辐射暴露后发生的乳头状癌相关。基因型与表型显著相关,特定互斥的分子改变促进肿瘤发展,启动以MAPK和PI3K-PTEN-AKT信号通路异常激活为特征的多步骤致瘤过程。分子改变正成为诊断和风险分层的生物标志物及侵袭性甲状腺癌的潜在治疗靶点。

要点

  • BRAF p.V600E与经典型乳头状癌相关,RAS点突变与滤泡型肿瘤相关。
  • 融合癌基因(如RET-PTC)与年轻患者及辐射暴露后乳头状癌相关。
  • 基因型与表型显著相关,分子改变可用于诊断、风险分层及靶向治疗。

核心结论

  • 滤泡细胞起源甲状腺肿瘤的分子改变与组织学类型显著相关,特定互斥的遗传改变通过激活MAPK和PI3K-PTEN-AKT通路促进肿瘤发生。
  • 分子改变正成为诊断、风险分层和侵袭性甲状腺癌潜在治疗靶点的生物标志物。

研究设计与样本

  • 本文为综述,总结了滤泡细胞起源甲状腺肿瘤的主要遗传改变及其临床病理相关性。

主要发现

  • BRAF p.V600E与经典型乳头状癌相关。
  • RAS点突变与滤泡型肿瘤(滤泡腺瘤、滤泡癌及乳头状癌滤泡型/伴乳头状核特征的非浸润性滤泡性甲状腺肿瘤)相关。
  • 融合癌基因(以RET-PTC为原型)与年轻患者及辐射暴露后发生的乳头状癌相关。
  • 基因型与表型显著相关,特定互斥的分子改变启动多步骤致瘤过程,特征为MAPK和PI3K-PTEN-AKT信号通路异常激活。

临床怎么用

  • 分子改变可用于甲状腺肿瘤的诊断和风险分层。
  • 分子改变可作为侵袭性甲状腺癌的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular pathology of thyroid tumours originating from follicular cells has greatly advanced in the past several years. Common molecular alterations, such as BRAF p.V600E, RAS point mutations, and fusion oncogenes (RET-PTC being the prototypical example), have been, respectively, associated with conventional papillary carcinoma, follicular-patterned tumours (follicular adenoma, follicular carcinoma, and the follicular variant of papillary carcinoma/non-invasive follicular thyroid neoplasm with papillary-like nuclear features), and with papillary carcinomas from young patients and arising after exposure to ionising radiation, respectively. The remarkable correlation between genotype and phenotype shows how specific, mutually exclusive molecular changes can promote tumour development and initiate a multistep tumorigenic process that is characterised by aberrant activation of mitogen-activated protein kinase and phosphoinositide 3-kinase-PTEN-AKT signalling. Molecular alterations are becoming useful biomarkers for diagnosis and risk stratification, and as potential treatment targets for aggressive forms of thyroid carcinoma. What follows is a review of the principal genetic alterations of thyroid tumours originating from follicular cells and of their clinicopathological relevance.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Acquaviva G, Visani M, Repaci A, et al. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance. Histopathology. 2018. PMID: 29239040. doi:10.1111/his.13380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。